Terms: = Bone cancer AND TRIM33, RFG7, 51592, ENSG00000197323, Q9UPN9, TF1G, FLJ32925, TIF1G, PTC7, TIFGAMMA, TIF1GAMMA
4 results:
1. trim33 loss in multiple myeloma is associated with genomic instability and sensitivity to PARP inhibitors.
McAvera RM; Morgan JJ; Herrero AB; Mills KI; Crawford LJ
Sci Rep; 2024 Apr; 14(1):8797. PubMed ID: 38627415
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a novel Calpain-2-SRC feed-back loop as necessity for β-Catenin accumulation and signaling activation in hepatocellular carcinoma.
Ma XL; Zhu KY; Chen YD; Tang WG; Xie SH; Zheng H; Tong Y; Wang YC; Ren N; Guo L; Lu RQ
Oncogene; 2022 Jul; 41(27):3554-3569. PubMed ID: 35697802
[TBL] [Abstract] [Full Text] [Related]
3. Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study.
Leurs A; Dubucquoi S; Machuron F; Balden M; Renaud F; Rogeau S; Lopez B; Lambert M; Morell-Dubois S; Maillard H; Béhal H; Hachulla E; Launay D; Sobanski V
Joint Bone Spine; 2021 Jan; 88(1):105048. PubMed ID: 32653653
[TBL] [Abstract] [Full Text] [Related]
4. trim33 prevents pulmonary fibrosis by impairing TGF-β1 signalling.
Boutanquoi PM; Burgy O; Beltramo G; Bellaye PS; Dondaine L; Marcion G; Pommerolle L; Vadel A; Spanjaard M; Demidov O; Mailleux A; Crestani B; Kolb M; Garrido C; Goirand F; Bonniaud P
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32184320
[TBL] [Abstract] [Full Text] [Related]
